Northern Trust Corp Landos Biopharma, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.6 - $1.5 $20,086 - $50,215	-33,477 Reduced 73.26%	12,219 $9,000
Q1 2022 May 13, 2022	SELL	$1.44 - $5.22 $447 - $1,623	-311 Reduced 0.68%	45,696 $67,000
Q4 2021 Feb 08, 2022	SELL	$4.7 - $15.0 $3,163 - $10,095	-673 Reduced 1.44%	46,007 $221,000
Q3 2021 Nov 15, 2021	SELL	$9.77 - $15.77 $266,125 - $429,559	-27,239 Reduced 36.85%	46,680 $682,000
Q2 2021 Aug 13, 2021	SELL	$9.26 - $12.53 $4,074 - $5,513	-440 Reduced 0.59%	73,919 $855,000
Q1 2021 May 12, 2021	BUY	$9.47 - $16.26 $704,179 - $1.21 Million	74,359 New	74,359 $716,000

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.